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Summary at a Glance 
The study presented, is the first to describe hypo-cellularity in the airway wall tissue of mild-
moderate COPDs and the consequential reduction in key inflammatory cell populations. Our 
current observation contests the currently held simplistic description of airway wall 
inflammation, which would have therapeutic implications. 
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Abstract  
Objective: To enumerate total cells and a number of inflammatory cell differentials in large 
airways (LA) versus small airways (SA) of mild-moderate COPD, and against appropriate 
controls. 
 
Methods: For LA we used endobronchial biopsies and for SA resected lung tissues. 
Immunostaining was enumerated (cells per square mm) for macrophages, neutrophils, CD4 
and CD8 T cells, in the LP up to 150 microns deep for LA and full wall thickness for SA.   
 
Results: We confirmed hypocellularity in the LA, and in the SA wall in smokers and COPD 
(p<0.001). LA cellularity was least in COPD-current smoker (CS) (p<0.01), while SA 
cellularity was similar across smoker/COPD groups. LA neutrophils were decreased in 
COPD-CS (p<0.01), while SA neutrophil counts were unchanged. Compared to controls, LA 
macrophage numbers in COPD were significantly lower (p<0.05), with SA macrophage 
numbers unchanged. A significant increase was observed in SA CD8+ cells in both normal 
smokers (p<0.01) and COPD-CS (p<0.001) but not in LA. 
 
Conclusion: These unique data indicate that the current model for airway wall inflammation 
in COPD is oversimplified, and contrast with the lumen at least in mild-moderate disease. 
Any abnormalities in airway wall cell differentials are small, though exaggerated in 
percentage terms. 
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Introduction  
COPD is a devastating global disease caused especially by cigarette smoking. The disease is 
characterized as slowly progressive fixed airway narrowing due to small airway fibrosis and 
obliteration. Up to fifty percent of COPD patients also go on to varying degree of lung 
destruction (emphysema) 
1
, and as a group, they are highly vulnerable to lung (airway) 
cancer, suggesting a common pathogenesis 
2
.   
 
The literature has reported convincing increases in both innate and adaptive cells in the 
airway lumen in COPD 
3-5
. It has also become accepted that airway wall inflammation also 
plays a critical role in COPD, but the evidence for this is quite limited. Better understanding 
of COPD pathophysiology requires more detailed information from airway wall tissues 
6
. 
 
There are reports of both increases and decreases in inflammatory cell profiles in the airway 
wall 
7-9
 . Selection of patients, inadequate approaches to controls, different sources of tissue 
acquisition, have been important variables. Studies aimed at relatively early disease before 
secondary complications such as chronic infection and cancer would be especially valuable 
for understanding fundamental pathogenesis. 
 
We have reported previously that smoking significantly decreased (rather than increased) 
large airway lamina propria (LP) total cellularity in mild to moderate COPD subjects 
10
. 
Surprisingly, few groups have examined this in airway tissue. Our hypo-cellularity finding in 
large airway biopsies questioned whether COPD can truly be regarded as an “airway wall” 
inflammatory disease. The limited literature evidence on cell differentials in the airway wall 
is also variable; thus, O'Shaughnessy et al. 
11
 showed that there was an increase in CD8+ T 
cells in COPD while the same cells were demonstrated to decrease progressively from mild to 
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moderate to severe COPD by Di Stephano et al, and reports on  macrophages and neutrophils 
have similarly varied in both directions 
4, 7, 12, 13
. This lack of consistency for cell differentials 
in the airway wall and our previous finding of overall hypo-cellularity, led us to believe that a 
new thorough, systematic investigation was warranted.  
 
We have also probed in more detail than previously the phenotypic specificity of the 
commonly used macrophage marker CD68 that has been used rather uncritically by 
respiratory scientists for many years. Evidence from non-respiratory research suggests that 
this marker is not unique to macrophages alone but are also expressed in other cell types, 
especially fibroblastic cells 
14
.  
 
 In the current study, we provide total cellularity, “inflammatory” cell differentials for 
neutrophils, CD68+ and CD8+ cells in both large and small airway tissue from mild to 
moderate, stable COPD subjects who were not on medication, and free from clinical 
infection.  
 
Materials and methods 
Ethics approval 
The Tasmania Health & Medical Human Research Ethics Committee approved the study 
(EC00337). 
Subjects  
Large airways (LA) biopsies (Ebb) from 72 subjects were recruited through advertisement. 
Bronchial biopsies (BB) from 20 normal lung function smokers (NLFS), 13 current smoking 
COPD (COPD-CS) and 14 ex-smokers with COPD (COPD-ES) were compared with 25 
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healthy non-smokers. COPD was diagnosed according to GOLD criteria. Subjects with other 
respiratory diseases, a history of recent acute exacerbation of COPD and those on systemic or 
inhaled corticosteroids were excluded from the study (Table 1). 
Small airways (SA) resected tissues - Forty patients consented for inclusion in this study. The 
subjects all had primary non-small cell lung cancer (NSCLC), with an approximately equal 
distribution of squamous and adenocarcinoma. Eighteen had demonstrated GOLD stage I/II 
COPD on spirometry (FER<70%) and were classified as current or ex-smokers (12 months 
since smoking cessation). Eleven individuals were current smokers with no evidence of 
airflow obstruction (NLFS). Subjects with systemic or inhaled corticosteroids were excluded 
from the study. Tissue from ten non-smokers was obtained from Prof Jim Hogg`s bio-bank at 
the University of British Columbia and included as a control group (NC) for comparison 
(Table 1). All these slides were scrutinized by an expert local academic pathologist (HKM) 
for normality.  
Tissue section acquisition and processing 
EBB from the LA and surgical resection material well away from the primary tumour, and 
containing non-cancer affected SA, and NC tissues were fixed in formalin within minutes of 
surgery. At processing, tissue blocks of the LA and SA (<2 mm internal diameter) were 
embedded in paraffin.  
Immunostaining 
Sections were cut at 3-microns from individual paraffin-embedded blocks. Immunostaining 
for neutrophils with anti Human Neutrophil elastase (1:100 dilution) (Dako, clone NP57, 
catalog # M0752),  macrophages with anti Human CD68 (1:400 dilution) (Dako, clone KP1, 
catalog # M0814), CD8 and CD4 T cells with anti-CD8 (Leica Novo Castra, clone 4B11, 
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catalog # NCL-CD8-4B11) and anti-CD4 (Leica Novo Castra, clone 1F6, catalog # NCL-
CD8-4B11) (1:20 dilution) antibodies respectively, for 1 hour at room temperature. Species-
appropriate isotype-matched immunoglobulin G (X0931 clone DAK-GO1; Dako) was 
incorporated. Bound antibodies were elaborated using peroxidase-labeled Envision 
(catalogue number K4001; Dako) and DAB (catalogue number K3468; Dako).    
Tissue section quantification 
Computer-assisted image analysis was performed with a Leica DM 2500 microscope (Leica 
Microsystems), Leica DFC495 camera (Leica Microsystems) and Image Pro Plus 7.0 (Media 
Cybernetics,) software. Five random fields for both LA and SA were chosen for 
comprehensive analysis without ad hoc area selection, muscle bundles and glands were 
excluded from the area surveyed. The observer was blinded to subject and diagnosis.    
Briefly: Stained cells were counted in the Lamina Propria (LP) up to 150 microns deep for 
LA and full thickness airway wall (up to 100 microns deep) in the SA wall; cells per mm
2
 
area were calculated. Stained cells in the epithelium and Rbm were counted and presented per 
mm of Rbm length. For total cell counts, haematoxylin stained nuclei were considered as an 
individual cell, and measured with similar strategies as mentioned above. 
Statistical analysis 
Based on the distributions, the data here are represented as mean plus SD, or as medians plus 
ranges; one way ANOVA parametric tests (Tukey, comparing means across groups) or non-
parametric (Kruskal–Wallis, comparing medians across groups of interest) were performed. 
Specific group differences were then explored as appropriate according to prior hypotheses 
and the structure of the data using the two-tailed T-test or Mann–Whitney U test. 
Results 
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Total cells 
Cell density was greater in SA and LA in normal controls (p<0.01), with cells per mm
2
 of LP 
compared to diseased. A decrease in overall cell numbers was observed in both LA LP 
(p<0.01) and SA wall p<0.001) in COPD when compared to normal non-smokers. In NLFS 
in large airway, total cell numbers were intermediate (p<0.01) while in ex-smokers the cell 
numbers were essentially back to NC levels though with wider variation (p=0.15). In the SA, 
total cell numbers were significantly fewer compared to normal controls in all smoker/COPD 
groups with little difference between these three (Fig 1 A. and B.).  
Neutrophils 
Neutrophil numbers were similar between the SA and LA in non-smoker controls. Neutrophil 
numbers in the pathological groups in large airways reflected the changes in total cell counts 
i.e. were reduced with least density observed in COPD-CS (p<0.01). In SA, however, 
neutrophil density was little different from normal in all groups, even if apparently (non-
significantly) slightly reduced in the NLFS (Fig 1 C. and D.).  
CD68+ cells  
 We observed two morphologically variable populations of CD68+ cells: round macrophage-
like and spindle-shaped cells, which we will refer to as macrophages and fibroblast-like cells 
respectively (Fig 2 A. and B). In normal LA these CD68+ fibroblast-like cells were much 
more numerous than macrophages, but in contrast, macrophages dominated the SA CD68+ 
profile (Fig 3, Fig 2 C and D).  
In COPD-CS LA, compared to normal controls, we found fewer macrophages (p<0.05), 
while in contrast, macrophages in the NLFS were significantly higher (p<0.001) than normal. 
In ex-smoker COPD subjects macrophages numbers were close to normal levels. In SA, 
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although  macrophage numbers were high generally, we found no significant change from 
normal in their numbers in smoker/COPD groups (Fig 3).  
Fibroblast-like cells were slightly higher in normal LA than normal SA but not significantly 
so (p=0.09). Generally, there was a reduction in all smoker/COPD groups in large airways 
(significant only for NLFS, p<0.01) but fibroblast-like cell densities were unchanged in 
corresponding small airways (Fig 3).  
Lymphocyte sub-types (Fig 4) 
In the LA wall, the lymphocyte populations studied were dominated by the CD8+ phenotype. 
Both CD8+ and CD4+ T cells were found to be lower than normal in the smoker/COPD 
groups but with some substantial changes in their ratio, especially in the COPD-CS where 
there was an even more marked relative excess of CD8+ over CD4+ lymphocytes (Fig 4D).   
There were many fewer CD4+ T cells throughout the airways, and indeed so few in the small 
airway that we did not formally count them. In contrast in SA, CD8+ cells tended to be 
higher than normal across all clinical groups, and especially so in COPD-CS (p<0.01).  
Inflammatory cell profile in airway epithelium and reticular basement membrane  
(Rbm)  
Overall the inflammatory cell densities in the airway epithelium and Rbm were far lower in 
comparison to the LP. Although the absolute number was small, a significant increase above 
normal was observed for macrophages in the epithelium of NLFS when compared to normal 
controls (Table 2).  
Discussion 
 In contrast to the current belief of COPD pathology being primarily an inflammatory airway 
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disease, we have found that the main finding in the COPD “airway wall” is a reduction in 
total cellularity at least in the mild-moderate disease. This overall decrease was accompanied 
by quite small fluctuations in specific inflammatory cell types; the most marked change was a 
general increase in macrophages in the small airway wall compared to the large airways, but 
this was in both healthy controls and the diseased as well. Changes in neutrophil numbers 
largely tracked total cell counts. In the COPD large airway wall,  CD8+ T cells were the 
dominant lymphocyte phenotype over CD4+T cells, and were the only cell type found to be 
significantly increased in COPD in the  small airway wall.  
These data are unique in their comprehensive nature, although the importance of sampling the 
airway wall has been emphasised as needed to compliment more easily obtained luminal cell 
counts in BAL or sputum 
15
. The activation of an innate neutrophil and macrophage reaction 
in the airway lumen in COPD is well established. This may be because of smoking itself or 
secondary to infection, which may have a crucial role 
3, 5, 16
. 
 An earlier report 
7
 suggested a moderate increase in the number of neutrophils in the sub-
epithelial airway wall LP in large airway biopsies in mild to moderate COPD  in comparison 
to smokers, but typically this finding is difficult to evaluate since there was no normal control 
group.  Our study suggests, in contrast, that in the airway wall the neutrophils are reduced in 
stable COPD subjects especially in the large airway LP. These data also suggest that the 
neutrophils trend back towards normal levels in ex-smoker COPD, suggesting mainly a 
smoking and to a lesser extent a COPD effect.  
For the small airways, published neutrophil data have been both limited and contradictory. 
Studies conducted by Lams et al. 
12
 suggested no change in smokers, which was similar to the 
conclusion of Hogg et al. in mild COPD subjects 
17
, while more recent evidence suggested a 
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small increase in neutrophil numbers in mild-moderate COPD patients 
13
. Our findings again 
showed no significant change in COPD subjects in comparison to either NLFS or NC. 
 The lack of neutrophilia in the airway wall of smokers and COPD could be hypothesised as 
being due to active egress of neutrophils into the airway lumen, though there was no obvious 
gradient of wall neutrophils from deep to superficial (epithelium) 
6, 18
.  
We also demonstrated a significant decrease in the number of macrophages in the large 
airway wall in COPD. Interestingly, macrophages were increased in NLFS, but it seems 
doubtful that this reaction is related to COPD development. Our macrophage findings are 
contrary to those of Di Stephano et al. 
7
 who suggested a small increase in large airway 
macrophages in COPD, but they only had smoking controls.  
In the current study, we have shown morphological variation in cells expressing the CD68 
epitope. Thus, we have observed two phenotypically distinct populations staining with CD68; 
one is more rounded and darkly staining and considered as typical macrophages 
phenotypically, while the others more lightly stained, spindly and fibroblast-like. This duality 
of CD68 staining has been previously shown in other disease tissues and in-vitro 
14, 19-21
 but 
so far has received little attention in the respiratory literature.  
The small airway wall had far greater number of both “true” tissue macrophages and also the 
more fibroblast-like CD68+ cells. This would be consistent with small airway fibrosis, but 
this was belied by the uniform numbers across groups with no signal here for COPD. The 
macrophage phenotypes have been established in recent years; macrophages can exist in the 
pro-inflammatory, tissue-destructive M1 phenotype and also as a phagocytic, anti-
inflammatory, anti-bacterial and pro-fibrotic M2 phenotype 
22
. Preliminary data 
23
 indicate 
that in the airway wall there may be phenotype shift from M2 to M1 macrophages, which 
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could perhaps be the strongest signal found for a true inflammatory signal but needs 
confirmation. 
The decrease in both CD8+ and CD4+ T cells in the large airway LP in COPD   are 
contradictory to  findings from O’ Shaughnessy et al, where both CD4+ and CD8+ T cell 
numbers were said to be increased, at least in those with “chronic bronchitis” 
11
. The 
difference in result may be a consequence of this phenotypic co-morbidity absent in our 
subjects. However, we are in agreement with the one other report 
8
.  
Our observations on CD8+ to CD4+ T cell ratios did suggest that the large airway wall in 
COPD is immunologically skewed toward CD8+ T cells, perhaps a response to the 
susceptibility of  COPD patients to airway viral infection 
13, 24
. The decrease in CD4+ T cell 
in COPD could be attributed to the presence of suppressor CD8+ T cells co-expressing 
CD103, that reduce the proliferation of CD4+ T cells 
24
, and this should be studied.  CD8+ T 
cells were decreased in large airway LP with both smoking and COPD but CD4+ cells 
markedly more.  
The current report is limited to the more highly cited “classical” inflammatory cells. In 
addition, we have previously observed an increase in mast cells in COPD large airways LP 
25
, 
and are studying small airway mast cells. Others have looked at dendritic cells (CD83+) and 
found them to be few and variable in number, and reduced essentially to zero in the airways 
in COPD 
26
. Our assessment of CD11c+ dendritic cells in COPD large airway LP found them 
to be too few to analyse 
27
. There are even fewer data available on eosinophils in the airways 
wall of COPD patients, and these are variable and contradictory 
9
 
28
, but absolute numbers 
were consistently very low.  
In conclusion, we have found that there is a marked decrease in total cellularity in both large 
and small airway walls of smokers and especially in COPD. This change is reflected in a 
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decrease in the number of inflammatory cells in the airway wall in these clinical groups. One 
is left very hard-put to defend the currently prevalent dogma that COPD is inherently an 
airway (wall) inflammatory disease; at most the small change in CD8+ to CD4+ T cell 
balance in the large airways might fit the bill.  
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Table 1. Demographic details and lung function data for participants 
Groups NC NLFS COPD-CS COPD-ES 
Tissue 
source 
LA SA LA SA LA SA LA SA 
Subjects 
(n) 
25 10 20 11 13 9 14 10 
Age 
(years) 
44 
(20-68) 
68 
(63-75) 
50 
(30-66) 
70 
(52- 79) 
61 
(46-78) 
64 
(59 -78) 
62 
(53-69) 
68 
(56-85) 
Smoking 
(Pack-Years) 
0 0 
32 
(10-57) 
33 
(3-60) 
45 
(18-78) 
28.5 
(2-50) 
51 
(18-150) 
33 
(18-36) 
FEV1 
/FVC 
82 
(71-88) 
80.6 
(77-86) 
77 
(70-96) 
76 
(70-90) 
59 
(46-68) 
66 
(60-70) 
57 
(38-68) 
64 
(55-69) 
 
LA- Large Airways; SA- Small Airways; 
Data expressed as medians and ranges. NC- normal control; NLFS-normal lung function 
smokers; COPD-CS current smoker COPD; COPD-ES ex-smoker; 
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Table 2. 
Epithelium 
Large 
Airways 
Neutrophils 
Macrophages 
(CD68+) 
Fibroblasts  
(CD68+) 
CD8+ CD4+ 
NC 0.4 (0-10) 0 (0-2.5) 0 (0-9.3) 3.7 (0-13) 0 (0-1.7) 
NLFS 0.5 (0-5.6)  2 **(0-6.5) 1.1 (0-4.9) 7.3(0.5-21.8) 0 (0-4.1) 
COPD-CS 0 (0-7.5) 0 #(0-3.9) 0.5 (0-9.3) 5.4 (1-23) 0 (0-0.9) 
COPD-ES 0.4 (0-2) 1.9 #(0-1.8) 0.2(0-3.15) 5 (1-25.6) 0 (0-3.2) 
Small Airways      
NC 0 (0-0.5) 2.1(0-6.4) 0.5 (0-3.2) 0.5 (0-9.1) - 
NLFS 0 (0-1.4) 3.6 (0.4-9.4) 1.0 (0-6.5) 1.3 (0-12) - 
COPD-CS 0.5 (0-2.4)  3.4(1.2-5.3) 0.5 (0-3.6) 2.6(0-11.3) - 
COPD-ES 0.2 (0-3.7) 2.3 (0.3-6.2) 1.0 (0-3.6) 0.48 (0-2.2) - 
Rbm 
Large 
Airways 
Neutrophils Macrophages 
(CD68+) 
Fibroblasts  
(CD68+) 
CD8+ CD4+ 
NC 3.0 (0-13.29) 0 (0-0.36) 0 (0-2.3)       0 (0-4) 0 (0-1.1) 
NLFS 2.5 (0.6-9.6) 0 (0-1.8)* 0 (0-3.4)   0 (0-2.7) 0 (0-0.4) 
COPD-CS 0.5 (0-10.26) 0 (0-0.33) 0 (0-2.3)   0 (0-2.1) 0 
COPD-ES 0.8 (0-7) 0 (0-0.17) 0 (0-2.3)  0(0-1.9) 0 
Small Airways      
NC 0.4 (0-4.3) 0.0 (0-1.5) 0.0 (0-1.5) 0 (0-1.2) - 
NLFS  0 (0-0.97) 0.5 (0-2.17) 0.4 (0-2.17) 0 (0-0.4) - 
COPD-CS  0 (0-1.65) 0 (0-1.0) 0.4 (0-1.0) 0 (0-0.4) - 
COPD-ES 0 (0-2.5)  0 (0-0.45) 0.3 (0-0.45) 0 (0-0.6) - 
 
Cell numbers in the epithelium and Rbm per mm of Rbm length. Data are presented as 
medians (range); ** & * represents p<0.01 & p<0.05 compared to NC, respectively; # 
represents p<0.05 compared to NLFS.   
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Figure 1. Total number of cells per square mm of the airway wall examined: (A). Large 
Airways; (B), Small Airways. Neutrophils per square mm of the airway wall examined: (C), 
Large Airways; (D), Small Airways 
Figure 2. Illustrates the presence of two morphologically distinct populations of CD68+ in 
(A). Large Airways and (B). Small Airways (400X magnification). (C) and (D), represent 
percentages of the total CD68+ for each morphological phenotype. 
Figure 3. A, B, C, and D represents the data for CD68+ve round-shaped macrophages and 
spindle-shaped fibroblast-like cell numbers per square mm of airway wall examined.  
Figure 4. Number of CD8+ve T cells per square mm of airway wall examined: (A), Large 
and (B), Small airways. (C), CD4+ve T cells in LA. (D), Ratio of CD8+ to CD4+ T cells in 
the LA LP. 
 
 
Page 19 of 27
Editorial Office: respirology@resphealth.uwa.edu.au; Editors-in-Chief: Philip Bardin and Paul Reynolds
Respirology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
CONFIDENTIAL for peer review only
  
 
 
Figure 1. Total number of cells per square mm of the airway wall examined: (A). Large Airways; (B), Small 
Airways. Neutrophils per square mm of the airway wall examined: (C), Large Airways; (D), Small Airways.  
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Figure 2. Illustrates the presence of two morphologically distinct populations of CD68+ in (A). Large Airways 
and (B). Small Airways (400X magnification). (C) and (D), represent percentages of the total CD68+ for 
each morphological phenotype  
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Figure 3. A, B, C, and D represents the data for CD68+ve round-shaped macrophages and spindle-shaped 
fibroblast-like cell numbers per square mm of airway wall examined.  
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Figure 4. Number of CD8+ve T cells per square mm of airway wall examined: (A), Large and (B), Small 
airways. (C), CD4+ve T cells in LA. (D), Ratio of CD8+ to CD4+ T cells in the LA LP.  
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